BRUNSWICK ($BC) is expected to release its quarterly earnings data on Thursday, January 29th before market open, per Finnhub. Analysts are expecting revenue of $1,245,082,931 and earnings of $0.59 per share.
You can see Quiver Quantitative's $BC stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
BRUNSWICK Insider Trading Activity
BRUNSWICK insiders have traded $BC stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $BC stock by insiders over the last 6 months:
- NANCY E COOPER has made 0 purchases and 2 sales selling 498 shares for an estimated $30,071.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
BRUNSWICK Revenue
BRUNSWICK had revenues of $1.4B in Q3 2025. This is an increase of 6.82% from the same period in the prior year.
You can track BC financials on Quiver Quantitative's BC stock page.
BRUNSWICK Hedge Fund Activity
We have seen 200 institutional investors add shares of BRUNSWICK stock to their portfolio, and 182 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- AMERICAN CENTURY COMPANIES INC added 830,451 shares (+56.4%) to their portfolio in Q3 2025, for an estimated $52,517,721
- BANK OF NEW YORK MELLON CORP added 700,447 shares (+70.1%) to their portfolio in Q3 2025, for an estimated $44,296,268
- TURTLE CREEK ASSET MANAGEMENT INC. removed 648,394 shares (-18.1%) from their portfolio in Q3 2025, for an estimated $41,004,436
- MARSHALL WACE, LLP added 565,459 shares (+62.4%) to their portfolio in Q3 2025, for an estimated $35,759,627
- CITADEL ADVISORS LLC removed 552,067 shares (-97.5%) from their portfolio in Q3 2025, for an estimated $34,912,717
- FIL LTD added 548,395 shares (+34167.9%) to their portfolio in Q3 2025, for an estimated $34,680,499
- HARRIS ASSOCIATES L P removed 415,750 shares (-10.9%) from their portfolio in Q3 2025, for an estimated $26,292,030
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
BRUNSWICK Government Contracts
We have seen $89,064 of award payments to $BC over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- MECURY MARINE ENGINES FOR INSTRUCTIONAL VESSELS: $59,653
- 1. VIEW MOBILE KIT: $22,050
- 8M0077473 -IGNITION COIL 14360T74 - FUEL PUMP ASSY8M0234005 -LICENSE KEY-G3 8M6001744 -INJECTOR ASM-AIR88...: $7,360
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
BRUNSWICK Analyst Ratings
Wall Street analysts have issued reports on $BC in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Citigroup issued a "Buy" rating on 10/24/2025
- BMO Capital issued a "Outperform" rating on 10/24/2025
- Benchmark issued a "Buy" rating on 10/24/2025
- Truist Securities issued a "Buy" rating on 10/15/2025
To track analyst ratings and price targets for BRUNSWICK, check out Quiver Quantitative's $BC forecast page.
BRUNSWICK Price Targets
Multiple analysts have issued price targets for $BC recently. We have seen 11 analysts offer price targets for $BC in the last 6 months, with a median target of $74.0.
Here are some recent targets:
- James Hardiman from Citigroup set a target price of $100.0 on 01/14/2026
- Anna Glaessgen from Jefferies set a target price of $115.0 on 01/06/2026
- An analyst from Loop Capital set a target price of $74.0 on 12/23/2025
- Gerrick Johnson from Seaport Global set a target price of $90.0 on 12/08/2025
- Megan Alexander from Morgan Stanley set a target price of $72.0 on 10/27/2025
- Gerrick Johnson from BMO Capital set a target price of $75.0 on 10/24/2025
- Craig Kennison from Baird set a target price of $70.0 on 10/24/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
